Baird Medical Investment Holdings (BDMD) Accumulated Expenses (2023 - 2026)

Baird Medical Investment Holdings (BDMD) has reported Accumulated Expenses for 4 consecutive years, with $9.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accumulated Expenses rose 1321.03% year-over-year to $9.9 million in Q2 2026; TTM through Jun 2026 was $9.9 million, a 1321.03% increase from a year earlier, with the FY2025 full-year figure at $8.6 million, up 976.03% from the prior year.
• Accumulated Expenses was $9.9 million for Q2 2026 at Baird Medical Investment Holdings, up from $8.6 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $9.9 million in Q2 2026 and troughed at $693309.0 in Q2 2025.
• A 4-year average of $4.1 million and a median of $797912.0 in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses increased 6.3% in 2024 and soared 1321.03% in 2026, its largest moves.
• Over 4 years, Accumulated Expenses stood at $750635.0 in 2023, then rose by 6.3% to $797912.0 in 2024, then surged by 976.03% to $8.6 million in 2025, then gained by 14.75% to $9.9 million in 2026.
• The last three Accumulated Expenses figures came in at $9.9 million (Q2 2026), $8.6 million (Q4 2025), and $693309.0 (Q2 2025), per Business Quant data.